AUGMENTING MITOCHONDRIA IN IMMUNE CELLS FOR IMPROVED CANCER IMMUNOTHERAPY
Patent Cooperation Treaty
PCT/EP2023/067747
Filed on 2023-06-28
PCT/EP2023/067747
Filed on 2023-06-28
AUGMENTING MITOCHONTIRIA IN T CELLS FOR IMPROVED CANCER LMMUNOTHERAPY
US Application 63/356,456
Filed on 2022-06-28
Filed on 2022-06-28
MONOCLONAL ANTIBODIES THAT BIND THE JUXTA-MEMBRANE REGION OF MESOTHELIN AND USES THEREOF (R04 antibody)
Patent Cooperation Treaty
PCT/US2025/014973
Filed on 2025-02-07
PCT/US2025/014973
Filed on 2025-02-07
T CELL RECEPTORS RECOGNIZING R175H OR Y220C MUTATION IN P53
Taiwan
114110844
Filed on 2025-03-21
114110844
Filed on 2025-03-21
HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS
Japan
2025-003895
Filed on 2025-01-10
2025-003895
Filed on 2025-01-10
Compositions and Methods for Treating Cancer with Anti-CD38 Immunotherapy
Japan
2024-192788
Filed on 2024-11-01
2024-192788
Filed on 2024-11-01
Compositions and Methods for Treating Cancer with Anti-CD38 Immunotherapy
European Patent
19827967.1
Filed on 2021-06-17
19827967.1
Filed on 2021-06-17
Compositions and Methods for Treating Cancer with Anti-CD38 Immunotherapy
China
201980090184.6
Filed on 2021-07-23
201980090184.6
Filed on 2021-07-23
Compositions and Methods for Treating Cancer with Anti-CD38 Immunotherapy
Japan
2021-531048
Filed on 2019-11-27
2021-531048
Filed on 2019-11-27
Thalidomide Analogs and Methods of Use
United Kingdom
16782148.7
Filed on 2016-09-29
16782148.7
Filed on 2016-09-29